| SIBO is a condition that excessive and abnormal microbiota are present in the small intestine, which may cause chronic symptoms such as bloating, flatulence, pain, or diarrhea. Multiple studies have repeatedly revealed association between SIBO and inflammatory bowel disease (IBD). One-fourth of IBD patients may have SIBO, even when bowel inflammation has ceased. The potential development of SIBO in IBD patients may cause challenges in clinical management because both conditions yield very similar symptoms, while they are mutually responsive in terms of disease pathophysiology. Therefore, understanding and profiling of the prevalence and risk groups for SIBO among IBD patients should provide a practical approach toward untangling the complexity of clinical management. In the presentation I will report a preliminary data of a single-center, prospective study of SIBO breath test used to screen for IBD patients in Taiwan, summarize the subgroups with increased SIBO risks, and discuss about its implications in improving primary care of IBD patients. |
